Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis
about
Nicotine receptor partial agonists for smoking cessationVarenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherenceEffect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized ControlledMethodological issues in observational studies and non-randomized controlled trials in oncology in the era of big data.Smoking cessation and the cardiovascular patientEmerging drugs for the treatment of tobacco dependence: 2014 updateCardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort studyA systematic review of possible serious adverse health effects of nicotine replacement therapy.Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study.Pharmacology in peripheral arterial disease: what the interventional radiologist needs to know.Cardiovascular toxicity of nicotine: Implications for electronic cigarette use.Cardiovascular effects of electronic cigarettes.Clinician's guide to the updated ABCs of cardiovascular disease prevention.Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life settingVarenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Modeling the Health Effects of Expanding e-Cigarette Sales in the United States and United Kingdom: A Monte Carlo AnalysisCost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessationActivation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stressCould androgens be relevant to partly explain why men have lower life expectancy than women?Network Meta-analysis to Synthesize Evidence for Decision Making in Cardiovascular Research.Knowledge and Perceptions about Nicotine, Nicotine Replacement Therapies and Electronic Cigarettes among Healthcare Professionals in Greece.Health professionals in Flanders perceive the potential health risks of vaping as lower than those of smoking but do not recommend using e-cigarettes to their smoking patients.Effects of varenicline on sympatho-vagal balance and cue reactivity during smoking withdrawal: a randomised placebo-controlled trial.Adolescents' Perceptions of Health Risks, Social Risks, and Benefits Differ Across Tobacco Products.Smoking cessation: benefits versus risks of using pharmacotherapy to quit.Migraine and Stroke: What's the Link? What to Do?Adverse drug reactions: The importance of maintaining pharmacovigilanceCardiovascular adverse events associated with smoking-cessation pharmacotherapies.The safety of treatments for tobacco use disorder.Definition of Best Medical Treatment in Asymptomatic and Symptomatic Carotid Artery Stenosis.How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis.Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort.Treatment with bupropion and varenicline for smoking cessation and the risk of acute cardiovascular events and injuries: a Swedish case-crossover study.An update on the pharmacotherapeutic interventions for smoking cessation.Addictive drugs, arrhythmias, and cardiac inward rectifiers.Nicotine at clinically relevant concentrations affects atrial inward rectifier potassium current sensitive to acetylcholine.2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.A guideline for perioperative smoking cessation.Cigarette smoking causes epigenetic changes associated with cardiorenal fibrosis.Comprehensive review of cardiovascular toxicity of drugs and related agents.
P2860
Q24185773-1E755BD8-85C6-4FAB-9208-4F3152B48EADQ26751374-A4EBD9F7-C8C9-47BC-B615-38A9AFD16928Q26797327-1B8E9455-4EC4-411D-94E1-73867D2ECAE8Q27691076-B89638C5-F797-4232-8CE0-929010EE1174Q28082695-B22D05E2-D709-435E-A920-7FCAFCCBC3B4Q28236453-BD912E78-E757-48E5-8A9C-362FF0255D36Q28267175-BB8B1CA4-D198-4A76-A925-7C2486E3DA59Q30244886-8471D2E8-5423-4303-9EB7-A44F128B5D55Q33627663-E97F8B30-5296-4E83-A98C-4B164BCE0B9DQ34513880-F8F86BD2-9BB3-42D6-9E12-535D6478D98FQ34522178-CE0073B9-4D6C-4FA8-8F1B-0A187F6CD280Q34553905-EE86B390-5BA1-4AC7-95AA-ACC069F7E0D5Q35070830-D1A60B2E-48E4-4C31-A2C5-7AF5B765403CQ35884580-90313F3A-AEF3-4360-BAB9-7C9E979C5ACAQ35931738-020E0298-6832-45D7-8B2A-C4145A29BC76Q36124031-E8FD6BD5-91BB-46DB-8E6B-70718F415F14Q36486726-4C0BF8F5-1CF2-4C4E-903D-03B6021AF6C5Q36608114-350C51CA-49BA-476B-B512-918475994030Q36762079-B28502ED-CDCE-4F9A-8FF0-81DF0139C29BQ36837610-40EBD2CD-622F-41F4-A5F0-F62D398A0D70Q36938050-E7724116-884B-460C-B51F-AC8D026F0F79Q37035486-0E46F2FA-08B1-4787-A1B9-97F81937AA65Q37160483-FE710DFC-DB28-4EB1-988A-613AFFD55084Q37354883-9C7FBF54-B6C7-43E9-8133-FCA861E1C5EFQ37567160-E72F9394-4DD8-4A16-A584-FF887C391C9FQ37693868-98F51004-D650-4E4D-9E11-8A1207B74C50Q38264124-9436DB72-17C6-46D7-97EF-E99F8C8D4B4CQ38269624-E8886C39-B0E4-4254-B421-8C91CA151809Q38682466-8723E3D1-25D0-4990-BC05-375D60F59DC5Q38684426-64E4D1AA-C906-49CF-A85F-7646F9C4280BQ38720906-304D6798-A090-4C63-8636-5027E312CF06Q38730184-6CC9F6A9-48EE-4531-A26F-BDD10DDCBA51Q38736026-26E95A55-A6BC-4AA9-96AE-53EDDB3DDEDEQ38856723-1451B02C-516B-44E6-B759-B1C2D8D04E4DQ38865437-93E7BF2B-298C-44C0-AB81-8F62CAE3363BQ38979816-0727BA4D-C01D-4955-B1D3-E76D69198312Q39007236-5939D167-C0B4-424B-80DF-1080B362851BQ39112916-71BD6D36-BE6B-416B-A458-95D9F376DE17Q39241512-A80B1417-B42B-41C9-8D87-101CA2567CF6Q47556269-C223369A-E8AC-42E5-A98C-0FE6AED1A5BB
P2860
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cardiovascular events associat ...... apies: a network meta-analysis
@ast
Cardiovascular events associat ...... apies: a network meta-analysis
@en
Cardiovascular events associat ...... apies: a network meta-analysis
@nl
type
label
Cardiovascular events associat ...... apies: a network meta-analysis
@ast
Cardiovascular events associat ...... apies: a network meta-analysis
@en
Cardiovascular events associat ...... apies: a network meta-analysis
@nl
prefLabel
Cardiovascular events associat ...... apies: a network meta-analysis
@ast
Cardiovascular events associat ...... apies: a network meta-analysis
@en
Cardiovascular events associat ...... apies: a network meta-analysis
@nl
P2093
P2860
P921
P3181
P1433
P1476
Cardiovascular events associat ...... apies: a network meta-analysis
@en
P2093
Edward J Mills
Shawn Eapen
P2860
P3181
P356
10.1161/CIRCULATIONAHA.113.003961
P407
P577
2014-01-07T00:00:00Z